At brand-name prices ($16,000 for 16 months): approximately $485 per pound lost At compounded prices ($3,184 for 16 months): approximately $96 per pound lost This per-pound calculation illustrates how much more cost-effective compounded alternatives are
This allowed the researchers to document early, real-world changes as these medications became more widely available
Administration Technique Retatrutide is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm
The generic version is manufactured by Hikma Pharmaceuticals and is expected to be available nationwide, offering a more affordable option for those relying on this medication for diabetes management
periodic monitoring is prudent
They do not constitute clinical evidence of efficacy or safety in humans, and all reference to biological activity pertains strictly to preclinical research settings